P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
The function of p53 as a tumour suppressor has been attributed to its ability to promote cell death or permanently inhibit cell proliferation. However, in recent years, it has become clear that p53 can also contribute to cell survival. p53 regulates various metabolic pathways, helping to balance glycolysis and oxidative phosphorylation, limiting the production of reactive oxygen species, and contributing to the ability of cells to adapt to and survive mild metabolic stresses. Although these activities may be integrated into the tumour suppressive functions of p53, deregulation of some elements of the p53-induced response might also provide tumours with a survival advantage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autophagy is another cellular program that is triggered by cell stress and p53.195, 208”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Target genes directly regulated by p53 participate in multiple metabolic pathways.194, 195”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Additional signals and persistent stress can lead to sustained expression of p53 and activation of p16INK4A contributing to a long lasting cell cycle arrest (Sharpless and DePinho, 2006; Salama et al., 2014; Kruiswijk et al., 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Kruiswijk et al., 2015
In the citing paper
“Second, most types of cellular stress are able to induce a p53 response, but they all use different mechanisms to activate the protein [65, 66, 67].”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [67]
In the citing paper
“p53 also promotes fatty acid oxidation by activating the expression of CPT1C, MCD and PANK1.107”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [107]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Self-citationBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citationA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Cited by
Items 701–800 of 1,000
The Impact of p53 on Aristolochic Acid I-Induced Gene Expression In Vivo
Sborchia, M., Keun, H. C., Phillips, D. H., & Arlt, V. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246155 · Cited by 10
“p21 (encoded by Cdkn1a) is a mediator of cell cycle arrest [36].”
BackgroundYang, X. P., Wang, X., Li, Z., Duan, S., Li, H., Jin, J. J., Zhang, Z., & Gu, W. J. (2021) · Science Advances · doi:10.1126/sciadv.abi6684 · Cited by 11
Jorge, G. P., Módolo, D. G., Jaimes-Florez, Y. P., Fávaro, W. J., de Jesus, M. B., & Brocchi, M. (2022) · Letters in Applied Microbiology · doi:10.1111/lam.13777 · Cited by 10
“These results indicate that eukaryotic expression of the pYA4545 plasmid is an effective gene delivery vector for use in recombinant S. enterica Typhimurium. p53 is a transcription factor that induces apoptosis or cell cycle arrest (Kruiswijk et al. 2015).”
BackgroundLu, D., Shang, J., Guo, X., & Zhang, Y. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/7543619 · Cited by 11
Meher, R. K., Mir, S. A., & Anisetti, S. S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2219323 · Cited by 10
“In general, it is estimated that p53 is mutated in about 50% of all human cancers (Kruiswijk et al ., 2015; Muller & Vousden, 2014) Thus, mutant p53 in its entirety form is typically detected in tumors.”
BackgroundVirtual screening using covalent docking to find activators for G245S mutant p53
Omar, S. I., Lepre, M. G., Morbiducci, U., Deriu, M. A., & Tuszyński, J. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200769 · Cited by 10
Zhu, G., Yang, S., Wang, R., Lei, J., Ji, P., Wang, J., Tao, K. X., Chen, Y., Ge, S., & Wang, L. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s273578 · Cited by 10
Evaluation of autoantibody signatures in pituitary adenoma patients using human proteome arrays
Banerjee, A., Ray, A., Barpanda, A., Dash, A., Gupta, I., Nissa, M. U., Zhu, H., Shah, A., Duttagupta, S. P., Goel, A. H., et al. (2022) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.202100111 · Cited by 10
“A largepercentageof humanNFPAsexpress numerous SSTRs (somatostatin receptors) regulating phosphotyrosine phosphatase activity, leading to the inhibition of the voltage-dependent calcium channel activity [76].”
BackgroundTherapeutic targeting of mutated p53 in acute lymphoblastic leukemia
van Leeuwen, F. N. (2020) · Haematologica · doi:10.3324/haematol.2019.234872 · Cited by 10
“The high incidence of TP53 loss of function across human tumors relates to its central role as a transcription factor controlling cell cycle regulation in response to DNA damage, DNA repair, metabolic regulation, stem cell development and cell senescence.(2) In most hematologic malignancies, loss of p53 function is a…”
BackgroundGrowth Signaling Networks Orchestrate Cancer Metabolic Networks
Manning, B. D., & Dibble, C. C. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041543 · Cited by 12
Bahceci, D. H., & Choi, W. (2025) · Human Pathology · doi:10.1016/j.humpath.2025.105959 · Cited by 9
Pediatric and adult dilated cardiomyopathy are distinguished by distinct biomarker profiles
Gropler, M. R. F., Lipshultz, S. E., Wilkinson, J. D., Towbin, J. A., Colan, S. D., Canter, C. E., Lavine, K. J., & Simpson, K. E. (2021) · Pediatric Research · doi:10.1038/s41390-021-01698-x · Cited by 10
Suppression of p53 response by targeting p53-Mediator binding with a stapled peptide
Allen, B. L., Quach, K., Jones, T., Levandowski, C. B., Ebmeier, C. C., Rubin, J. D., Read, T., Dowell, R. D., Schepartz, A., & Taatjes, D. J. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110630 · Cited by 9
ARTS, an unusual septin, regulates tumorigenesis by promoting apoptosis
Bian, C., Su, J., Zheng, Z., Wei, J., Wang, H., Meng, L., Xin, Y., & Jiang, X. M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113281 · Cited by 9
Deng, Z., Sun, R., Han, X. M., Zhang, Y., Zhou, Y., Shan, Y., Xu, J., Li, X., He, F., & Fang, W. (2022) · Journal of Virology · doi:10.1128/jvi.01274-22 · Cited by 9
“A variety of stimulations, including DNA damage, oncogene activation, and nutrient fluctuation, could activate the p53 pathway to induce expression of a large number of downstream target genes, either to support cell survival or to mediate cell death (37, 38).”
BackgroundMüller, A., Weyerhäuser, P., Berte, N., Jonin, F., Lyubarskyy, B., Sprang, B., Kantelhardt, S. R., Salinas, G., Opitz, L., Schulz‐Schaeffer, W., et al. (2023) · Cells · doi:10.3390/cells12091290 · Cited by 10
RK, A. R. A., Arumugam, S., Muninathan, N., Baskar, K., Deepthi, S., & Dinesh Roy, D. (2024) · Cureus · doi:10.7759/cureus.60125 · Cited by 12
“…adapting to and surviving minimal stress circumstances, such as oxidative stress and metabolic stress, is one of its tumor-suppressing properties [14]. p53 is capable of triggering autophagy, which has been implicated in cancer suppression, along with its functions in inducing growth arrest,…”
BackgroundEllis, M. H., Stern, O. L., & Ashur‐Fabian, O. (2016) · Oncotarget · doi:10.18632/oncotarget.11443 · Cited by 10
“p53 is a master gene orchestrating an array of tumor suppressing activities in response to a variety of stress conditions [4, 5], including hypoxia.”
BackgroundA role of cytoplasmic p53 in the regulation of metabolism shown by bat-mimicking p53 NLS mutant mice
Sanford, J. D., Jin, A., Grois, G. A., & Zhang, Y. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111920 · Cited by 11
Genomic instability in individuals with sex determination defects and germ cell cancer
Krivega, M., Zimmer, J., Slezko, A., Frank‐Herrmann, P., Rehnitz, J., Hohenfellner, M., Bettendorf, M., Luzarowski, M., & Strowitzki, T. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01470-6 · Cited by 9
The Roles of MicroRNAs in Glioblastoma Biology and Biomarker
Sasayama, T., Tanaka, K., & Kohmura, E. (2016) · InTech eBooks · doi:10.5772/63243 · Cited by 12
“The mutation of p53 results in the inability to stop further cell-cycle progression triggered by oncogenic signals (63).”
BackgroundLiao, X., Huang, J., Lin, W., Long, Z., Xie, Y., & Ma, W. (2017) · DNA and Cell Biology · doi:10.1089/dna.2017.3962 · Cited by 9
“Once stabilized, p53 stands as the ‘‘guardian of the genome’’ through induction of apoptosis, cell cycle arrest, DNA repair, and senescence (Kruiswijk et al., 2015; Meek David, 2015; Laptenko and Prives, 2017).”
BackgroundPassow, C. N., Bronikowski, A. M., Blackmon, H., Parsai, S., Schwartz, T. S., & McGaugh, S. E. (2019) · Genome Biology and Evolution · doi:10.1093/gbe/evy273 · Cited by 9
Zmorzyński, S., Wojcierowska-Litwin, M., Kowal, M., Michalska-Jakubus, M. M., Styk, W., Filip, A. A., Walecka, I., & Krasowska, D. (2020) · BioMed Research International · doi:10.1155/2020/8465971 · Cited by 9
“NOTCH3 and TP53 signaling pathways are important in cell fate [15, 16].”
BackgroundLncRNA-HEIH is a Novel Diagnostic and Predictive Biomarker in Gastric Cancer
Chen, X., Sun, X., Li, X., Xu, L., & Yu, W. (2021) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2020.0270 · Cited by 9
“P53 is widely accepted as one of the most important tumor suppressor proteins (Kruiswijk et al. , 2015).”
Xu, S., Liu, D., Cui, M., Zhang, Y., Zhang, Y., Guo, S., & Zhang, H. (2022) · BioMed Research International · doi:10.1155/2022/1893351 · Cited by 10
“The p53 signalling pathway significantly contributed to cell cycle regulation, suppression of tumour expression, metabolism, aging, development, and reproduction [45].”
BackgroundRetractedLin, P., Qin, Q., Gan, X.-Y., Pang, J., Wen, R., He, Y., & Yang, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06347-z · Cited by 8
“…studies have reported that TP53 mutations are involved in a number of metabolic regulatory pathways, such as the balance of glycolysis and oxidative phosphorylation, limiting the production of reactive oxygen species, and contributing to the adaptation of cells to mild metabolic stress [23, 24].”
Pyrimidine synthase CAD deamidates and inactivates p53
Qi, Y., Tan, Z., Chen, H., Xiao, Z., Zhang, L., Wu, B., Liu, C., Gao, Y., Yang, X., Wu, L., et al. (2025) · Cell Research · doi:10.1038/s41422-025-01112-9 · Cited by 10
Chakraborty, K., & Francis, P. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105119 · Cited by 8
lncRNAs: Key Regulators of Signaling Pathways in Tumor Glycolysis
Wen, L., Tan, C., Ma, S., & Li, X. (2022) · Disease Markers · doi:10.1155/2022/2267963 · Cited by 9
“Stress conditions, such as oxidative damage, nutritional restriction, and DNA damage, can lead to p53 mutations and are associated with more than half of cancers [55].”
BackgroundSuppression of E6 Oncogene Induces Apoptosis in CaSki Cervical Cancer Cells
Rasi, F., Zarredar, H., Amini, M. A., Onsori, H., Dadashzadeh, K., Khanmohammadi, M., Vahedi, L., Mokhtarzadeh, A., Baradaran, B., & Baghi, H. B. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.10.3389 · Cited by 8
“This protein contains 160 amino acids with two zinc fingers bound by CXXC (Kruiswijk et al., 2015; Paek et al., 2016; Tomaić, 2016).”
BackgroundThe effect of trans-resveratrol on the expression of the human DNA-repair associated genes
Uchiumi, F., Arakawa, J., Takihara, Y., Akui, M., Ishibashi, S., & Tanuma, S. (2016) · Integrative Molecular Medicine · doi:10.15761/imm.1000246 · Cited by 10
Ogata, T., Nakamura, M., Sang, M., Yoda, H., Hiraoka, K., Yin, D., Sang, M., Shimozato, O., & Ozaki, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179884 · Cited by 8
Expression of EZH2 and P53 and their correlation in ovarian cancer tissues.
Zhai, L., Tai, W., Pan, Y., Luo, J., Ma, L., Zheng, Y., Guo, M.-Y., & Zhang, X. (2020) · PubMed · Cited by 12
Li, M., Tian, W., Wang, F., Yang, C., Zhang, L., Tang, Q., Liu, S., & Wang, F. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62493 · Cited by 9
“The p53 takes part in modulating cellular processes such as cell cycle arrest, apoptosis, development, differentiation, tissue homeostasis, and regeneration (Kruiswijk et al., 2015).”
BackgroundTumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC
Butera, G., Manfredi, M., Fiore, A., Brandi, J., Pacchiana, R., Giorgis, V. D., Barberis, E., Vanella, V. V., Galasso, M., Scupoli, M. T., et al. (2022) · Biomolecules · doi:10.3390/biom12020305 · Cited by 9
“Intrinsic and extrinsic stress signals are transferred to the p53 protein by post-translational modifications promoting p53 protein activation [31,32].”
BackgroundGuttiferone E Displays Antineoplastic Activity Against Melanoma Cells
Ribeiro, A. B., Nicolella, H. D., da Silva, L. H. D., Mejía, J. A. A., Tanimoto, M. H., Ambrósio, S. R., Bastos, J. K., Orenha, R. P., Parreira, R. L. T., & Tavares, D. C. (2022) · Planta Medica · doi:10.1055/a-1890-5446 · Cited by 9
“There are several pro-apoptotic transcriptional targets of P53, such as NOXA and PUMA genes, that induce cytochrome-c release from the mitochondria promoting apoptosis [14,17].”
BackgroundLv, D., Lai, Q., Zhang, Q., Wang, J., Li, Y.-C., Zeng, G., & Yin, J.-L. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11013 · Cited by 8
p53-mediated metabolic response to low doses of ionizing radiation
Nagpal, I., & Yuan, Z.-M. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2142983 · Cited by 9
“These observations suggest that p53 is a multifunctional stress-responsive protein that can sometimes support opposite functions, such as the pro-survival function distinct from its canonical pro-death activity (Kruiswijk et al. 2015).”
BackgroundPRPF8 controls alternative splicing of PIRH2 to modulate the p53 pathway and survival of human ESCs
Sun, Y., Zhang, L., Fang, Z., Liu, D., Shao, M., Liu, Y., Liao, B., & Jin, Y. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31066 · Cited by 9
“transcription factor, p53 can either activate or inhibit the expression of a broad spectrum of genes, playing essential roles in regulation of many cellular events (Aubrey et al., 2018; Kruiswijk et al., 2015).”
BackgroundLower MGMT expression predicts better prognosis in proneural-like glioblastoma.
He, Z.-C., Ping, Y., Xu, S., Lin, Y., Yu, S., Kung, H., & Bian, X. (2015) · PubMed · Cited by 8
Novel Insights into PML-Dependent Oncosuppression
Galluzzi, L. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.09.001 · Cited by 9
GPR158 in the Visual System: Homeostatic Role in Regulation of Intraocular Pressure
Itakura, T., Webster, A. R., Chintala, S. K., Wang, Y., González, J. M., Tan, J. C. H., Vranka, J. A., Acott, T. S., Craft, C. M., Saber, M. E. S., et al. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0135 · Cited by 8
“The tumor suppressor TP53 is activated by a variety of stresses, arresting growth by holding the cell cycle at the G1/S regulation point through its action as a transcription factor.(38) This suggested TP53 as a candidate mediator of the observed reversals.”
BackgroundResultInfluentialLiu, J., Chen, K., Liu, T.-B., Wang, Z.-Y., & Wang, L. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.130823 · Cited by 9
1H, 15N and 13C backbone resonance assignments of the acidic domain of the human MDMX protein
Song, Q., Liu, X., & Rainey, J. K. (2022) · Biomolecular NMR Assignments · doi:10.1007/s12104-022-10081-8 · Cited by 8
TP53LNC-DB, the database of lncRNAs in the p53 signalling network
Khan, M. R., Bukhari, I., Khan, R., Hussain, H. M. J., Wu, M., Thorne, R. F., Li, J., & Liu, G. (2018) · Database · doi:10.1093/database/bay136 · Cited by 8
Agamia, N., ElMulla, K. F., Ghazala, R. A., Alsayed, N. M., Abdelmaksoud, R., Elmonem, E. A., Talat, E. M., Zaki, I. N., Sabah, R. M., & Melnik, B. C. (2022) · Research Square · doi:10.21203/rs.3.rs-1609874/v2 · Cited by 8
Li, X., Shi, W., Zhang, Q., Lin, X., & Sun, H. (2025) · BMC Cancer · doi:10.1186/s12885-025-14392-6 · Cited by 7
“TP53 mutations, which disrupt cell cycle regulation and metabolic programming, were effectively captured in PET images, aligning with the Warburg effect where TP53-mutated tumors increase glycolytic flux even in the presence of oxygen [26].”
Merlin, J. P. J., Rajan, S. S., & Abrahamse, H. (2025) · Cancer Medicine · doi:10.1002/cam4.71032 · Cited by 7
p53 increases phospholipid headgroup scavenging in senescence
Yashinskie, J. J., Zhu, X., McGregor, G. H., Wessendorf-Rodriguez, K. A., Paras, K. I., Brunner, J. S., Jackson, B. T., Xie, A., Koche, R. P., Metallo, C. M., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-025-01853-0 · Cited by 10
“By inducing transcriptional programmes that favour nutrient oxidation over rampant glycolysis, p53 increases the efficiency by which cells convert available nutrients into ATP, thus maintaining continuous energy production despite restricted nutrient supply 10 .”
Mazumder, S., Bhattacharya, D., Lahiri, D., Nag, M., Maity, S., Raja, V., Sharma, S. K., Dwivedi, S. P., Rajeev, M., & Kadirov, I. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70136 · Cited by 10
“However, when the cell is not repairable, p53 triggers cells to undergo programmed cell death to prevent malignancy (Kruiswijk et al. 2015; Ma et al. 2022).”
Almeida, T. C., Melo, A. S., Lima, A. P. B., Branquinho, R. T., & da Silva, G. N. (2022) · Natural Product Research · doi:10.1080/14786419.2022.2151007 · Cited by 8
“Additionally, the functions of p53 extend to several non-apoptotic forms of cell death and other processes such as DNA repair (Kruiswijk et al. 2015), which are all known to affect anticancer drug responses.”
BackgroundSha, A., Chen, H., & Zhao, X. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116883 · Cited by 7
Wang, Y., Vadhan, A., Wu, C.-H., Hsu, C., Chen, Y., Chen, Y.-K., Chen, P., Nguyen, H., Chang, Y.-C., & Yuan, S. F. (2023) · Oncology Reports · doi:10.3892/or.2023.8620 · Cited by 7
Tong, Y., Gu, M., Luo, X., Qi, H., Jiang, W., Deng, Y., Wei, L., Liu, J., Ding, Y., Cai, J., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.005 · Cited by 7
ROS, Redox Regulation, and Anticancer Therapy
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_9 · Cited by 14
Wang, Y., Tian, X., Cheng, T., Liu, R., & Han, F. (2024) · Natural Product Research · doi:10.1080/14786419.2024.2373957 · Cited by 8
“For example, p53 exerts pro-apoptotic function through transcriptionally activating the expression of some pro-apoptotic BCL-2 family proteins (Kruiswijk et al. 2015).”
Han, H., Chen, W., Yang, J., Zhang, J., Li, Q., & Yang, Y. (2018) · New Journal of Chemistry · doi:10.1039/c8nj01870g · Cited by 7
Protein Network Analysis to Prioritize Key Genes and Pathway for Stress-Mediated Neurodegeneration
Srivastava, N., Mishra, B. N., & Srivastava, P. (2018) · The Open Bioinformatics Journal · doi:10.2174/1875036201811010240 · Cited by 9
Lesser, M. P., Thompson, M. M., & Walker, C. W. (2019) · Journal of Shellfish Research · doi:10.2983/035.038.0304 · Cited by 9
Metabolic targeting of malignant tumors: a need for systemic approach
Margetis, A. T. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04212-w · Cited by 7
“FoxO family of transcription factors controls anti-oxidant response and both regulates and is regulated by ROS through acetylation, phosphorylation, and ubiquitination; these transcription factors can promote apoptosis, senescence or survival in a context-dependent manner (Klotz et al. 2015; Kruiswijk et al. 2015).”
Backgroundp53 Tumor Suppressor: Functional Regulation and Role in Gene Therapy
Farooq, Z., Wani, S., Ragunathrao, V. A. B., Kochhar, R. K., & Anwar, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105029 · Cited by 8
Telomere maintenance mechanisms in neuroblastoma: New insights and translational implications
Werr, L., Rosswog, C., Bartenhagen, C., George, S. L., & Fischer, M. (2024) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2024.100156 · Cited by 8
Effect of cigarette smoke exposure and mutant Kras overexpression on pancreatic cell proliferation
Glauert, H. P., Elliott, R. S., Han, S. G., Athey, M., Lee, E. Y., & Gairola, C. G. (2017) · Oncology Letters · doi:10.3892/ol.2017.5606 · Cited by 7
“KrasG12D's inhibitory effect on p53 protein levels is consistent with the effect of p53 on increasing apoptosis but inhibiting cell proliferation (11).”
BackgroundTang, X., Chen, Z., Deng, M., Wang, X., Nie, Q., Xiang, J., Xiao, Y., Yang, L., Liu, Y., & Li, D. W. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666190111154450 · Cited by 7
A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
Guan, Q., Zeng, Q., Jiang, W., Xie, J., Cheng, J., Yan, H., He, J., Xu, Y., Guan, G., Guo, Z., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.573787 · Cited by 7
“The p53 signaling pathway has been reported to be involved in cell cycle regulation and suppression of tumor expression (Hu et al., 2007; Kruiswijk et al., 2015; Tanikawa et al., 2017).”
BackgroundNuclear iASPP determines cell fate by selectively inhibiting either p53 or NF-κB
Ge, W., Wang, Y., Zheng, S., Zhao, D. H., Wang, X., Zhang, X., & Hu, Y. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00582-1 · Cited by 11
The Biology of Chronic Lymphocytic Leukemia: Diagnostic and Prognostic Implications
Moia, R., Patriarca, A., Schipani, M., & Gaïdano, G. (2021) · The Cancer Journal · doi:10.1097/ppo.0000000000000534 · Cited by 7
Sanford, J. D., Yang, J., Han, J., Tollini, L. A., Jin, A., & Zhang, Y. (2021) · BMC Molecular and Cell Biology · doi:10.1186/s12860-021-00385-3 · Cited by 7
p66α Suppresses Breast Cancer Cell Growth and Migration by Acting as Co-Activator of p53
Zhang, Q., Zhang, Y., Zhang, J., Zhang, D., Li, M., Han, Y. Y., Zhang, H., Song, L., Wang, J., Hou, Z., et al. (2021) · Cells · doi:10.3390/cells10123593 · Cited by 9
Rancourt, A., Sato, S., & Satoh, M. S. (2022) · eLife · doi:10.7554/elife.72498 · Cited by 7
Lan, A., Chen, J., Li, C., Jin, Y., Wu, Y., Dai, Y., Jiang, L., Li, H., Peng, Y., & Liu, S. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021617 · Cited by 9
“p53 signaling system anomalies are seen in almost all human tumors, and p53 mutations are found in over 50% of malignant tumors [3] and 30% of breast cancers [4], which is the main driving force behind p53 being a hot topic.”
BackgroundAn AMPK-dependent, non-canonical p53 pathway plays a key role in adipocyte metabolic reprogramming
Wang, H., Wan, X., Pilch, P. F., Ellisen, L. W., Fried, S. K., & Liu, L. (2020) · eLife · doi:10.7554/elife.63665 · Cited by 8
“Different regulatory mechanisms for the activation of each pathway have been identified, including upstream signaling, post-translational modifications, and downstream activated target genes (Vousden and Prives, 2009a; Kruiswijk et al., 2015).”
BackgroundPan, M., Sun, Q., Li, C., Tai, R., Shi, X., & Sun, C. (2022) · Biochemistry and Cell Biology · doi:10.1139/bcb-2021-0558 · Cited by 8
Rmaileh, A. A., Solaimuthu, B., Tanna, M., Khatib, A., Yosef, M. B., Hayashi, A., Lichtenstein, M., & Shaul, Y. D. (2020) · Biomolecules · doi:10.3390/biom10050701 · Cited by 7
“org, [58]) as references to generate this map.”
BackgroundUmezawa, Y., Kurosu, T., Akiyama, H., Wu, N., Nogami, A., Nagao, T., & Miura, O. (2016) · Oncotarget · doi:10.18632/oncotarget.9844 · Cited by 7
“com/oncotarget inactivates the Cdk2 kinase mainly through induction of the Cdk inhibitor p21 expression [4, 5].”
BackgroundResultInfluentialPrognosis-related metabolic genes in the development of colorectal cancer progress and perspective
Miao, Y., Quan, W., Dong, X., Gan, J., Ji, C.-F., Wang, J., & Zhang, F. (2023) · Gene · doi:10.1016/j.gene.2023.147263 · Cited by 6
HIV-1-related factors interact with p53 to influence cellular processes
Liu, S., Guo, T., Hu, J., Huang, W., She, P., & Wu, Y. (2023) · AIDS Research and Therapy · doi:10.1186/s12981-023-00563-7 · Cited by 7
“Since its discovery many years ago, protein 53 (p53) has been a transcription factor encoded by the tumor protein 53 (TP53) gene in humans [5]. p53 has been an essential anti-tumor factor, and its response can be activated by various stress signals, including ribosome stress, activation of…”
BackgroundHDAC6 preserves BNIP3 expression and mitochondrial integrity by deacetylating p53 at lysine 320
Lee, S.-I., Seo, Y., Oanh, H., Go, H., Go, H., Kim, M. H., & Lee, J. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149320 · Cited by 8
Natural compounds targeting cellular redox homeostasis in malignancies
Li, X., & Li, D. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.14.43 · Cited by 7
“Some enzymes also produce ROS, such as nicotinamide adenine dinu - cleotide phosphate (NADPH) oxidases (NOXs).”
BackgroundInfluentialMicroRNA regulating metabolic reprogramming in tumor cells: New tumor markers
Felipe‐Abrio, B., & Otero-Albiol, D. (2016) · Cancer translational medicine · doi:10.4103/2395-3977.196909 · Cited by 7
Marruecos, L., Manils, J., Moreta-Moraleda, C., Gómez, D., Filgaira, I., Serafín, A., Cañas, X., Espinosa, L., & Soler, C. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03638-3 · Cited by 6
Dynamically softened substrate regulates malignancy of breast tumor cells
Hu, M., Xu, L. L., Huang, W., Hu, D., Ren, K., & Ji, J. (2021) · Science China Materials · doi:10.1007/s40843-021-1631-3 · Cited by 7
The Four Homeostasis Knights: In Balance upon Post-Translational Modifications
Pieroni, S., Castelli, M., Piobbico, D., Ferracchiato, S., Scopetti, D., Di-Iacovo, N., Fazia, M. A. D., & Servillo, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214480 · Cited by 6
Du, J., Su, W., Li, X., Zu, T., Bai, J., Zhang, W., & Zhou, W. (2023) · Oral Diseases · doi:10.1111/odi.14613 · Cited by 6
SCARNA10 regulates p53 acetylation-dependent transcriptional activity
Wu, Y., Sun, Y., Xu, B., Yang, M., Wang, X., & Zhao, X. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.05.091 · Cited by 7
Rocha, V. A., de Aquino, A. M., Magosso, N. S. S., Souza, P. V., Justulin, L. A., Domeniconi, R. F., Barbisan, L. F., Romualdo, G. R., & Scarano, W. R. (2023) · Reproductive Toxicology · doi:10.1016/j.reprotox.2023.108449 · Cited by 6
Akshatha, H. S., Bhagyalalitha, M., Pujar, G. V., Hariharapura, R. C., Sethu, A. K., Singh, M., & Bidye, D. P. (2023) · Future Medicinal Chemistry · doi:10.4155/fmc-2023-0061 · Cited by 8
Yang, A., Liu, J., Li, M., Zhang, H., Zhang, X., & Wu, L. (2024) · Diagnostic Pathology · doi:10.1186/s13000-024-01528-8 · Cited by 8
Mpakou, V., Papadavid, E., Kontsioti, F., Konsta, E., Vikentiou, M., Spathis, A., Papageorgiou, S. G., Vasilatou, D., Gkontopoulos, K., Mpazani, E., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170186 · Cited by 6
Activity of resveratrol triesters against primary acute lymphoblastic leukemia cells
Urbaniak, A. J., Delgado, M., Kacprzak, K. M., & Chambers, T. C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.04.066 · Cited by 6
Defining key concepts of intestinal and epithelial cancer biology through the use of mouse models
Phesse, T. J., Durban, V. M., & Sansom, O. J. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx080 · Cited by 7
“Separate studies from the groups of Tyler Jacks and Gerard Evan demonstrated that genetically restoring p53 function resulted in regression of lymphomas and sarcomas in mouse models, thus providing proof of principal that reactivation of p53 function could be therapeutically attractive for treating cancer (91,92) As o…”
Wang, Y., Li, W., Huang, F., Wu, X., Chen, W., Dong, M., & Zhou, J. H. S. (2020) · Environmental Toxicology · doi:10.1002/tox.23053 · Cited by 6
“Another transcription factor, which modulates survival and death of various cells, is the tumor suppressor p53.(13) During”
BackgroundWu, D., Chen, D., Shi, W., Liu, W., Zhou, W., & Qian, J. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/9936932 · Cited by 6
“TP53 plays an important role in senescence or apoptosis in cells with damaged genomes [49].”
The ubiquitin-proteasome system in normal hearing and deafness
Pouyo, R., Chung, K., Delacroix, L., & Malgrange, B. (2021) · Hearing Research · doi:10.1016/j.heares.2021.108366 · Cited by 6
AbdelAzizS.A., A., MohamedA., F., ZahkoukS.A., M., & AliR.A., M. (2017) · International Journal of Advanced Research · doi:10.21474/ijar01/3376 · Cited by 6
“The resulting increase in p53 level leads either to the induction of the cell cycle arrest or apoptosis that suppress the tumor growth (Kruiswijk et al., 2015).”
BackgroundEffects of UV on apoptotic factors in lens epithelial cells of an animal model
Lv, J., & Xing, Y. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6435 · Cited by 8
Mamidi, M. K., Samsa, W. E., Bashur, L. A., Chen, Y., Chan, R., Lee, B., & Zhou, G. D. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30254 · Cited by 6
“The tumor suppressor p53 tightly regulates cell survival in response to genotoxic damage and other types of cellular stress (Kruiswijk et al., 2015).”
BackgroundZhou, Q., Yu, H., Dong, A., Yi, J., Li, J., Li, X., Zhou, L., Qiu, Q., Lü, B., Zhang, H., et al. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101211 · Cited by 5
González‐Ruiz, I., Samayoa‐Descamps, V., Guagua-Cortez, K. A., González‐Moles, M. Á., & Ramos‐García, P. (2025) · Cancers · doi:10.3390/cancers17152427 · Cited by 6
“The tumor suppressor protein p53 (also known as the guardian of the genome), encoded by the TP53 gene, plays a central role in maintaining genomic integrity through its involvement in cell cycle arrest, apoptosis, and DNA repair [57–59].”
Metadata
- Authors
- Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Vousden, Karen H.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2015-06-23
- Volume
- 16
- Issue
- 7
- Pages
- 393-405
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1890766043
- Cited by
- 1,080
- References
- 177
- Citations by year
- 2026: 37 · 2025: 54 · 2024: 67 · 2023: 119 · 2022: 133 · 2021: 148 · 2020: 108 · 2019: 104 · 2018: 110 · 2017: 101 · 2016: 84 · 2015: 15
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Cancer Research UK (C596/A10419, 18274)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- p53, tumour suppressor, cell survival, cell death, glycolysis, oxidative phosphorylation, reactive oxygen species, cancer metabolism, tumor progression
- MeSH terms
- Animals, Cell Survival, Humans, Tumor Suppressor Protein p53, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.